These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Clinical evaluation of a new factor VIII concentrate in hemophilic children]. Carnelli V; Cultrera S; Simoni L; Pasqui G; Busso B; Bagnato L Pediatr Med Chir; 1983; 5(3):49-55. PubMed ID: 6417627 [TBL] [Abstract][Full Text] [Related]
26. Use of implantable venous access devices in children with severe hemophilia: benefits and burden. Van Dijk K; Van Der Bom JG; Bax KN; Van Der Zee DC; Van Den Berg MH Haematologica; 2004 Feb; 89(2):189-94. PubMed ID: 15003894 [TBL] [Abstract][Full Text] [Related]
27. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia. Thornburg CD; Pipe SW Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098 [No Abstract] [Full Text] [Related]
28. [A randomized in vivo trial of 3 factor VIII preparations]. Jacobsen L; Clausen C; Jans H; Gormsen J Ugeskr Laeger; 1983 Mar; 145(10):739-42. PubMed ID: 6407165 [No Abstract] [Full Text] [Related]
29. Impact of treatment regimen with moroctocog alfa (AF-CC) on bleeding rates in paediatric patients with severe haemophilia A. Smith MP; Rupon J; Wali Y; Rimawi H; Korth-Bradley J; Smith L; Rendo P Haemophilia; 2020 Sep; 26(5):e232-e235. PubMed ID: 32497363 [No Abstract] [Full Text] [Related]
33. Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate. Mäkipernaa A; von Bonsdorff L Haemophilia; 2008 May; 14(3):612-4. PubMed ID: 18312362 [No Abstract] [Full Text] [Related]
34. Pharmacokinetics of factor VIII in hemophilia A patients assessed by frequency response method. Durisová M; Dedík L; Bátorová A; Sakalová A; Hedera J Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):217-26. PubMed ID: 9646284 [TBL] [Abstract][Full Text] [Related]
35. Use of cryoprecipitate antihaemophilic factor for the treatment of haemophilia. Bloom AL; Emmanuel JH Q J Med; 1968 Apr; 37(146):291-302. PubMed ID: 5656159 [No Abstract] [Full Text] [Related]
36. [Experience concerning substitution therapy of adult haemophiliacs in the Grisons (author's transl)]. Hartmann S Ther Umsch; 1979 Apr; 36(4):301-6. PubMed ID: 451948 [No Abstract] [Full Text] [Related]
37. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group. Kessler CM; Ludlam CA Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193 [No Abstract] [Full Text] [Related]
38. Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate. Guérois C; Laurian Y; Rothschild C; Parquet-Gernez A; Duclos AM; Négrier C; Vicariot M; Fimbel B; Fressinaud E; Fiks-Sigaud M Thromb Haemost; 1995 Feb; 73(2):215-8. PubMed ID: 7792732 [TBL] [Abstract][Full Text] [Related]
39. [A case of urinary tract hemorrhage in a child with hemophilia A treated with cryoprecipitate AHG]. Foltyn H; Wróbel I Pediatr Pol; 1969 Sep; 44(9):1155-7. PubMed ID: 5364502 [No Abstract] [Full Text] [Related]
40. Home infusion--the new approach. Vaugh E Health Care (Don Mills); 1980 Oct; 22(10):44, 46. PubMed ID: 10318526 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]